跳至主要内容
临床试验/CTRI/2019/11/022115
CTRI/2019/11/022115尚未招募3 期

EVALUATION OF TAMSULOSIN VERSUS MIRABEGRON IN URETERIC STENT RELATED SYMPTOMS- A RANDOMISED CONTROLLED TRIA

Dr Josef B Pachikara0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who have underwent semirgid ureteroscopy with DJ stenting.
  • 2. Only patients with uncomplicated ureteric calculi.
  • 3 Patients aged 18 years to 60 years.

排除标准

  • 1. Patients with growth in Urine culture or having symptomatic urinary tract infection.
  • 2. Patients who may need bilateral stent insertion for acute obstruction / obstructive uropathy
  • 3. Male patients with history of prostatic enlargement, prostatitis or prostatic cancer related lower urinary tract symptoms
  • 4. Females with lower urinary tract symptoms related to any form of urinary incontinence, uterine/cervical/vaginal prolapse, or obstruction related to malignancy.
  • 5. History of chronic or recent α-blocker or analgesic drug use were excluded.
  • 6. Pregnancy,
  • 7. Bleeding disorders,
  • 8. Patients with concomitant other lower tract pathology like bladder cancer, bladder outlet obstruction with or without stones, urethral stricture.
  • 9. Patients with simultaneous renal calculus.
  • 10. Patients who underwent open surgery for ureteric calculi previously.
  • 11. Patients not fulfilling inclusion criteria.

研究者

发起方
Dr Josef B Pachikara

相似试验